Evidence map›Paper›PMID 37229218›Full record

ArticleBeilstein journal of organic chemistry2023

Synthesis, structure, and properties of switchable cross-conjugated 1,4-diaryl-1,3-butadiynes based on 1,8-bis(dimethylamino)naphthalene.

Semyon V Tsybulin, Ekaterina A Filatova, Alexander F Pozharskii, Valery A Ozeryanskii, Anna V Gulevskaya

Abstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Semyon V TsybulinDepartment of Chemistry, Southern Federal University, Zorge str. 7, Rostov-on-Don 344090, Russian Federation.ORCID https://orcid.org/0000-0001-5033-8454
Ekaterina A FilatovaDepartment of Chemistry, Southern Federal University, Zorge str. 7, Rostov-on-Don 344090, Russian Federation.ORCID https://orcid.org/0000-0002-6042-8194
Alexander F PozharskiiDepartment of Chemistry, Southern Federal University, Zorge str. 7, Rostov-on-Don 344090, Russian Federation.ORCID https://orcid.org/0000-0003-3612-1392
Valery A OzeryanskiiDepartment of Chemistry, Southern Federal University, Zorge str. 7, Rostov-on-Don 344090, Russian Federation.ORCID https://orcid.org/0000-0002-3797-3805
Anna V GulevskayaDepartment of Chemistry, Southern Federal University, Zorge str. 7, Rostov-on-Don 344090, Russian Federation.ORCID https://orcid.org/0000-0002-5356-3267

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A set of novel 1,4-diaryl-1,3-butadiynes terminated by two 7-(arylethynyl)-1,8-bis(dimethylamino)naphthalene fragments was prepared via the Glaser-Hay oxidative dimerization of 2-ethynyl-7-(arylethynyl)-1,8-bis(dimethylamino)naphthalenes. The oligomers synthesized in this way are cross-conjugated systems, in which two conjugation pathways are possible: π-conjugation of 1,8-bis(dimethylamino)naphthalene (DMAN) fragments through a butadiyne linker and a donor-acceptor aryl-C≡C-DMAN conjugation path. The conjugation path can be "switched" simply by protonation of DMAN fragments. X-ray diffraction, UV-vis spectroscopy and cyclic voltammetry are applied to analyze the extent of π-conjugation and the efficiency of particular donor-acceptor conjugation path in these new compounds. X-ray structures and absorption spectra of doubly protonated tetrafluoroborate salts of the oligomers are also discussed.

Indexed as

1,4-diaryl-1,3-butadiynes1,8-bis(dimethylamino)naphthalenecross-conjugated systemsdonor–acceptor systemsGlaser–Hay reaction

Identifiers

PMID37229218
PMCPMC10204205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.